By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ImmunoCellular Therapeutics, Ltd 

23622 Calabasas Road
Suite 300
Calabasas  California  91302  U.S.A.
Phone: 818-264-2300 Fax: 818-224-5287



Company News
ImmunoCellular (IMUC) Announces Pricing Of Public Offering Of Convertible Preferred Stock And Warrants 7/18/2017 8:56:33 AM
ImmunoCellular (IMUC) Receives Notice From NYSE MKT For Noncompliance With Continued Listing Standards 6/30/2017 8:44:47 AM
Money Problems Push SoCal's ImmunoCellular (IMUC) To Suspend Trial, Seek Strategic Alternatives 6/21/2017 5:52:17 AM
ImmunoCellular Therapeutics (IMUC) Announces Data From ICT-121 Phase I Trial In Recurrent Glioblastoma At ASCO 2017 6/6/2017 7:37:28 AM
ImmunoCellular Therapeutics (IMUC) Announces First Quarter 2017 Financial Results 5/16/2017 10:56:28 AM
ImmunoCellular Therapeutics (IMUC) And Memgen Announce Letter Of Intent For Potential Joint Immuno-Oncology Collaboration 3/23/2017 8:28:32 AM
ImmunoCellular Therapeutics (IMUC) Receives Audit Opinion With Going Concern Explanation 3/15/2017 9:54:39 AM
ImmunoCellular Therapeutics (IMUC) Announces Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 3/10/2017 7:34:17 AM
ImmunoCellular Therapeutics (IMUC) To Report Fourth Quarter And Full Year 2016 Financial Results On March 9, 2017 3/7/2017 9:35:28 AM
ImmunoCellular Therapeutics (IMUC) Provides Update On ICT-107 Phase III Glioblastoma Trial And Announces Advances In Stem-To-T-Cell Research Program 3/6/2017 6:23:52 AM